Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support


Breath Analyzer Market was valued at USD 2.15 billion in 2019 and it is expected to reach at USD 5.65 billion by 2031, at a CAGR of 15.91% over the forecast period (2024-2031).

The breath analyzers industry is very competitive. It is also extremely fragmented, with numerous small and medium-sized businesses present due to low entry and exit barriers for new entries. Companies that launch innovative goods have a lot of room to develop since there is a lot of demand for them. Market participants are implementing strategic initiatives such as product advances, sales and marketing activities, and distribution network growth, among other things. For instance, FoodMarble Digestive Health Ltd introduced the AIRE 2, a personal digestive breath testing. 'Drägerwerk AG & Co. KGaA (Germany)', 'MPD, Inc (US)', 'Lifeloc Technologies (US) ', 'BACtrack, Inc. (US)', 'Quest Products, Inc. (US)', 'Akers Biosciences, Inc. (US)', 'Intoximeter, Inc. (US) ', 'AK GlobalTech Corporation (US)', 'Alcohol Countermeasure Systems Corporation (Canada)', 'EnviteC-Wismar GmbH (Germany)', 'Lion Laboratories Ltd. (UK)', 'Pas Systems International (US)', 'Guth Laboratories, Inc (US)', 'Alcolizer Technology (Australia)', 'Alcopro, Inc (US)', 'Andatech Private Ltd (Australia)', 'Alere (US)', 'C4 development (China)', 'Advanced Safety Devices (US)', 'Bedfont Scientific Limited (UK)'

Alcohol and drug misuse is on the rise

The COVID-19 pandemic had a significant influence on the market. The pandemic also spurred demand for non-invasive testing methods that could be carried out while keeping to social distancing standards. As a result, breathalysers have developed as realistic options for diagnosing COVID-19 and other medical disorders without the danger of transmission. Imec and diagnostics, for example, created a standard chip-based Breathalyzer Test for COVID-19. As a result, the business was able to create and sell a COVID-19 test based on breath testing, as opposed to standard COVID-19 testing based on saliva, blood, or a sample from the nose/throat cavity.

In 2021, North America dominated the market with the highest revenue share. This dominance can be attributed to a highly developed economy, strong product adoption rates, and increased awareness of road traffic safety. Because of the increasing use of these gadgets, the area is likely to maintain its dominance over the projection period. The market is predicted to develop rapidly due to an increase in fast and simple product approval procedures.

Feedback From Our Clients

Global Breath Analyzer Market

Product ID: SQMIG30L2231